Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Explore linked clinical trials.285 results · Page 1 of 12
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Not applicable | 2026-10-08 | NCT07866612 | |
| Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia | Disease Attributes, Healthcare-Associated Pneumonia, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumonia, Ventilator-Associated, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 4 | 2026-10-02 | NCT07856355 | |
| Arsenic Trioxide Combined With Chemotherapy for Relapsed SHH-Activated and/or TP53-Mutant Medulloblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, epithelial neoplasm, glioma, medulloblastoma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 2 | 2026-10-02 | NCT07856069 | |
| Venipuncture Via Nurse-AI Collaboration | Peripheral Venous Access Establishment; Peripheral Venous Cannulation for Contrast-enhanced CT/MRI Examination | Not yet recruiting | Not applicable | 2026-10-02 | NCT07854626 | |
| DV Plus Toripalimab With Cetirizine and Mecobalamin Pretreatment in Patients With Locally Advanced Unresectable or Metastatic Bladder Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Not yet recruiting | Phase 1 | 2026-10-01 | NCT07853053 | |
| Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial | Breast Cancer Invasive | Recruiting | Not applicable | 2026-09-30 | NCT06716073 | |
| Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab | Euthyroid With Thyroid Antibodies; Recurrent Pregnancy Loss | Recruiting | Not applicable | 2026-09-30 | NCT06652113 | |
| A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs | Unresectable Gallbladder Cancer | Recruiting | Phase 2 | 2026-09-30 | NCT06423170 | |
| Intranasal Dexmedetomidine for Severe Dental Anxiety: a Randomized Trial | Dental Anxiety | Not yet recruiting | Not applicable | 2026-09-30 | NCT05500261 | |
| Case Management for Microtia | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ear Diseases, microtia, otorhinolaryngologic disease | Recruiting | Not applicable | 2026-09-29 | NCT07846345 | |
| SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 3 | 2026-09-29 | NCT06627712 | |
| Absorbable Hemostatic Fluid Gelatin Trial | Surgical Bleeding | Not yet recruiting | Phase 3 | 2026-09-21 | NCT07830797 | |
| Chidamide in HR-AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Not stated | 2026-09-16 | NCT07822789 | |
| Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-09-16 | NCT05165225 | |
| Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-09-15 | NCT07796880 | |
| Early Endotoxin Burden Reduction With oXiris in Septic Shock Patients Requiring CRRT | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, toxic shock syndrome, urinary system disorder | Recruiting | Not applicable | 2026-09-08 | NCT07807410 | |
| Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study | Unresectable Hepatocellular Carcinoma | Recruiting | Phase 2 | 2026-09-08 | NCT07806292 | |
| Efficacy and Safety of Anrikefon Injection for Multimodal Postoperative Analgesia in Patients Undergoing Laparoscopic Hepatectomy | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Not yet recruiting | Phase 4 | 2026-09-03 | NCT07801183 | |
| Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-09-01 | NCT07179744 | |
| Efficacy Analysis of Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Therapy in the Treatment of Chronic Subjective Tinnitus | Chronic Subjective Tinnitus | Not yet recruiting | Not applicable | 2026-08-31 | NCT07794462 | |
| Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma | Disease Attributes, Disease Progression, Head and Neck Neoplasms, Neoplasms by Site, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, head and neck cancer, neoplasm | Recruiting | Not stated | 2026-08-31 | NCT06755567 | |
| RC48 in Combination With AK104 and Bevacizumab in OCCC | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 2 | 2026-08-27 | NCT06540729 | |
| OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-08-24 | NCT07137832 | |
| Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL | primary central nervous system lymphoma | Recruiting | Phase 2 / Phase 3 | 2026-08-19 | NCT07185373 | |
| A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 / Phase 3 | 2026-08-18 | NCT07544056 |